Advertisement
News
Subscribe to MDT Magazine News

Australia to host IOF Regionals - 2nd Asia-Pacific Osteoporosis and Bone Meeting

February 17, 2011 11:34 pm | by International Osteoporosis Foundation | Comments

IOF is pleased to announce the 2nd Asia-Pacific Osteoporosis and Bone Meeting, to be held in conjunction with the Australian & New Zealand Bone & Mineral Society (ANZBMS) Annual Scientific Meeting and with the Japanese Bone and Mineral Research Society

TOPICS:

Competing risks analysis highlights new targets in preventing ESRD and death of diabetics

February 17, 2011 9:32 pm | by EurekAlert | Comments

(University of Helsinki) Many patients with Type 1 diabetes and overt nephropathy develop End-Stage Renal Disease (ESRD) and/or succumb to a premature death. The competing risks of death and ESRD may confound the estimates of risk for each outcome. Now, the researchers have...

TOPICS:

Stretching before a run does not prevent injury

February 17, 2011 7:34 pm | by EurekAlert | Comments

(American Academy of Orthopaedic Surgeons) Stretching before a run neither prevents nor causes injury, according to a study presented today at the 2011 Annual Meeting of the American Academy of Orthopaedic Surgeons.

TOPICS:
Advertisement

ASU forms innovative international health care partnership

February 17, 2011 4:33 pm | by Arizona State University | Comments

ASU and Taiwan's Chang Gung University have formalized an agreement to establish an international Biosignatures Center aimed at the prevention, early detection, diagnosis, and treatment of cancer and other diseases.read more

TOPICS:

HealthSouth 4Q profit surges on tax benefit

February 17, 2011 1:45 pm | by The Associated Press | Comments

HealthSouth Corp., which provides inpatient rehabilitation services, said Thursday its fourth-quarter surged on a hefty income tax benefit.The company earned $772.7 million, or $7.16 per share, up from $32.1 million, or 35 cents per share, a year earlier. Revenue rose 7 percent to $520.7...

Chelsea Therapeutics offering $35 million in stock

February 17, 2011 12:45 pm | by The Associated Press | Comments

Chelsea Therapeutics International Ltd. said Thursday that it plans a public offering of $35 million in stock.Deutsche Bank Securities Inc. is acting as sole book-running manager.The company has about 41.9 million shares of common stock outstanding.Shares of Chelsea Therapeutics fell 16 cents,...

Leading Hong Kong Hospital Is Recipient and First to Order Two TomoHD(R) Treatment Systems Worldwide

February 17, 2011 11:45 am | by The Associated Press | Comments

http://www.tomotherapy.com () —TomoTherapy Incorporated (http://www.tomotherapy.com/) (NASDAQ: TOMO), maker of advanced radiation therapy solutions for the treatment of cancer and other diseases, today announced that it has shipped its 350th treatment system. The milestone unit is the first...

SME Honors Loyal Member with the 2011 Award of Merit

February 17, 2011 11:36 am | by Society of Manufacturing Engineers | Comments

DEARBORN, Mich., February 17, 2011 — The Society of Manufacturing Engineers (SME) announced today that it is recognizing Robert V. Petrach Jr., CMfgE, with the 2011 Award of Merit, for the contributions he has made to the his local chapter, affiliated chapters and the Society...

Advertisement

Drug Follows Melanoma Wherever It Goes

February 17, 2011 11:36 am | by Massachusetts Institute of Technology | Comments

Researchers are testing the safety of a nanoparticle that targets cancer cells.

Important Information: Additional Recalled Lubricating Jelly Products

February 17, 2011 10:45 am | by The Associated Press | Comments

Following our communication (http://www.hc-sc.gc.ca/ahc-asc/media/advisories-avis/_2011/2011_06-eng.php) regarding Bowers Medical Ltd. voluntary recall of Triad Group's sterile lubricating jelly, Health Canada is informing Canadians that additional health products have been identified....

Brupbacher Prize goes to B. Vogelstein and J. Hoeijmakers for research on colorectal and skin cancer

February 17, 2011 10:34 am | by EurekAlert | Comments

(University of Zurich) Today, the Charles Rodolphe Brupbacher Prize for Cancer Research 2011 goes to two researchers who have contributed to better understanding of the genetics underlying the growth of tumors. Oncologist Bert Vogelstein has demonstrated how sequential accumulation...

TOPICS:

Warfarin Sodium Tablets (Jantoven), 3mg: Recall - Mislabeled Bottles Containing Higher Dosage

February 17, 2011 10:33 am | by U.S. Food & Drug Administration | Comments

10mg strength tablets found in bottle labeled as 3 mg.

Intrinsic Enrolls First Patient in Barricaid® Trial

February 17, 2011 10:32 am | by Bio-Medicine.Org | Comments

WOBURN, Mass., Feb. 17, 2011 /- Intrinsic Therapeutics, Inc., a developer of novel lumbar spine anulus closure devices, announced today that it has enrolled the first patient, December 17, 2010, in a Randomized Clinical Trial of its Barricaid® device. Barricaid is designed to prevent...

TOPICS:

Success Factors and Failure Points in Biopharmaceutical Product Launches

February 17, 2011 9:36 am | by Bio-Medicine.Org | Comments

CHAPEL HILL, N.C., Feb. 17, 2011 /- Recent biopharmaceutical product launches have produced both noteworthy failures and successes. Faced with a continually evolving launch landscape, organizations are rethinking the factors that play the biggest role in the current launch environment. In...

TOPICS:

FDA Warns Against Certain Uses of Asthma Drug Terbutaline for Preterm Labor

February 17, 2011 9:35 am | by Bio-Medicine.Org | Comments

SILVER SPRING, Md., Feb. 17, 2011 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration is warning that terbutaline administered by injection or through an infusion pump should not be used in pregnant women for prevention or prolonged (beyond 48-72 hours) treatment of preterm...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading